Artículos relacionados
aducanumab
Alzheimer's drug approved by the FDA in 2021 despite a near-unanimous advisory committee vote against approval, citing conflicting efficacy evidence and safety risks including brain bleeds.
Artículos relacionados
Alzheimer's drug approved by the FDA in 2021 despite a near-unanimous advisory committee vote against approval, citing conflicting efficacy evidence and safety risks including brain bleeds.